284
Participants
Start Date
February 15, 2022
Primary Completion Date
June 2, 2027
Study Completion Date
August 25, 2027
Dupilumab
Injection solution subcutaneous
Placebo
Injection solution SC
Fexofenadine (loratadine if not available)
Tablet or capsule Oral
RECRUITING
Investigational Site Number : 1580001, Taipei
RECRUITING
Investigational Site Number : 1580004, New Taipei City
RECRUITING
Investigational Site Number : 1580002, Taoyuan
RECRUITING
Investigational Site Number : 1580003, Kaohsiung City
COMPLETED
Investigational Site Number : 0320005, Buenos Aires
COMPLETED
Investigational Site Number : 0320001, Buenos Aires
RECRUITING
Investigational Site Number : 3480001, Budapest
COMPLETED
Investigational Site Number : 0320006, Buenos Aires
RECRUITING
Investigational Site Number : 3480005, Debrecen
RECRUITING
Investigational Site Number : 0320007, Maroochydore
COMPLETED
Investigational Site Number : 0320003, Birtinya
RECRUITING
Investigational Site Number : 3480003, Szeged
RECRUITING
Investigational Site Number : 3480002, Zalaegerszeg
RECRUITING
Icahn School of Medicine at Mount Sinai- Site Number : 8400034, New York
RECRUITING
Investigational Site Number : 2760002, Berlin
RECRUITING
Investigational Site Number : 7240004, Córdoba
COMPLETED
Investigational Site Number : 4100004, Ansan-si
RECRUITING
FoxHall Dermatology- Site Number : 8400042, Washington D.C.
RECRUITING
Investigational Site Number : 3800002, Rozzano
RECRUITING
Investigational Site Number : 3800003, Milan
RECRUITING
Johns Hopkins Hospital- Site Number : 8400020, Baltimore
RECRUITING
Ospedale Sant' Anna- Site Number : 8400037, Como
RECRUITING
National Allergy and Asthma - North Charleston - Northside Drive- Site Number : 8400032, North Charleston
RECRUITING
Skin Care Physicians of Georgia - Macon- Site Number : 8400030, Macon
RECRUITING
Aeroallergy Research Laboratory- Site Number : 8400036, Savannah
RECRUITING
Palm Harbor Dermatology- Site Number : 8400024, Belleair
RECRUITING
University of Miami Hospital- Site Number : 8400011, Miami
RECRUITING
Investigational Site Number : 7240001, Pontevedra
RECRUITING
Dermatology Specialists Research (DS Research) - Kentucky- Site Number : 8400031, Louisville
RECRUITING
Investigational Site Number : 3800007, Varaždin
RECRUITING
Dawes Fretzin Clinical Research- Site Number : 8400007, Indianapolis
COMPLETED
Investigational Site Number : 4100003, Busan
RECRUITING
Investigational Site Number : 3800005, Florence
RECRUITING
Investigational Site Number : 2760003, Mainz
RECRUITING
Investigational Site Number : 3920001, Elk Grove Village
RECRUITING
Investigational Site Number : 3800004, Torette
RECRUITING
Universitätsklinikum Frankfurt- Site Number : 8400039, Frankfurt
RECRUITING
The Asthma and Allergy Center- Site Number : 8400014, Bellevue
RECRUITING
Complete Dermatology - Sugar Land- Site Number : 8400046, Sugar Land
RECRUITING
Investigational Site Number : 3800006, Naples
RECRUITING
Allergy & Rheumatology- Site Number : 8400038, La Jolla
COMPLETED
Kern Allergy and Medical Research- Site Number : 8400016, Bakersfield
RECRUITING
Investigational Site Number : 1560003, Beijing
RECRUITING
Investigational Site Number : 1560001, Shanghai
RECRUITING
Investigational Site Number : 1560011, Suzhou
RECRUITING
Investigational Site Number : 1560002, Hangzhou
RECRUITING
Investigational Site Number : 1560009, Chongqing
RECRUITING
Investigational Site Number : 1560008, Wuhan
RECRUITING
Investigational Site Number : 1560006, Guangzhou
RECRUITING
Investigational Site Number : 1560005, Guangzhou
RECRUITING
Investigational Site Number : 1560004, Chengdu
RECRUITING
Investigational Site Number : 1240001, Calgary
COMPLETED
Investigational Site Number : 1240008, Edmonton
RECRUITING
Investigational Site Number : 1240002, London
COMPLETED
Investigational Site Number : 1240003, Markham
RECRUITING
Investigational Site Number : 1240006, Toronto
COMPLETED
Investigational Site Number : 1240005, Montreal
RECRUITING
Investigational Site Number : 1240004, Verdun
COMPLETED
Investigational Site Number : 0320004, Athens
RECRUITING
Investigational Site Number : 3800001, Rome
RECRUITING
Investigational Site Number : 3920007, Urayasu-shi
RECRUITING
Investigational Site Number : 3920003, Obihiro
RECRUITING
Investigational Site Number : 3920006, Sapporo
RECRUITING
Investigational Site Number : 3920004, Habikino
RECRUITING
Investigational Site Number : 3920002, Sakai
RECRUITING
Investigational Site Number : 3920005, Izumo
RECRUITING
Investigational Site Number : 6160001, Krakow
RECRUITING
Investigational Site Number : 6160007, Wroclaw
ACTIVE_NOT_RECRUITING
Investigational Site Number : 6160003, Wroclaw
RECRUITING
Investigational Site Number : 6160003, Wroclaw
RECRUITING
Investigational Site Number : 6160008, Warsaw
RECRUITING
Investigational Site Number : 6160005, Warsaw
RECRUITING
Diabetol- Site Number : 8400047, Prešov
COMPLETED
Investigational Site Number : 4100005, Seoul
COMPLETED
Investigational Site Number : 4100002, Seoul
COMPLETED
Investigational Site Number : 4100001, Seoul
RECRUITING
Investigational Site Number : 7240003, Barcelona
RECRUITING
Investigational Site Number : 7240006, Barcelona
RECRUITING
Investigational Site Number : 7240005, Alicante
COMPLETED
Investigational Site Number : 0320002, Leicester
Lead Sponsor
Sanofi
INDUSTRY